Drug Type Chemical drugs |
Synonyms CaV2.3 ion channel inhibitor(Lario) |
Target |
Mechanism CACNA1E inhibitors(calcium voltage-gated channel subunit alpha1 E inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Drug Resistant Epilepsy | Preclinical | GB | 25 Sep 2024 | |
Parkinson Disease | Preclinical | GB | 25 Sep 2024 | |
CDKL5 Deficiency Disorder | Preclinical | GB | 11 Dec 2023 | |
Epilepsy | Preclinical | GB | 11 Dec 2023 |